Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new 'Find contact information' label was added to the page to aid users in locating contact details. The site revision line was updated to Revision: v3.7.0, replacing the previous version.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study history was updated to record the latest revision (v3.6.6) and a new Study Status entry on 2026-08-25, superseding the previous revision (v3.6.5).SummaryDifference0.4%

- Check74 days agoChange DetectedA new revision entry, Revision: v3.6.5, is added to the study history and the previous Revision: v3.6.4 entry is removed, updating the version history on the page.SummaryDifference0.1%

- Check88 days agoChange DetectedA new Revision: v3.6.4 entry was added to the study record history. This indicates the page was updated to a newer software revision and continues version tracking of the record.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.